![Peter Ratcliffe](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 10 573 $ in data 30/06/2026
Peter John Ratcliffe is the founder of ReOx Ltd., founded in 2003, holding the title of Director since 2015.
Current jobs include Director-Target Discovery Institute at the University of Oxford, Director-Clinical Research at The Francis Crick Institute Ltd., Director at Target Discovery Institute, Non-Executive Director at Immunocore Ltd., Independent Non-Executive Director at Immunocore Holdings Plc since 2020, Member of the American Academy of Arts & Sciences, and Member of the European Molecular Biology Organization.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 27/05/2026 | 333 ( 0% ) | 10 573 $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| IMMUNOCORE HOLDINGS PLC | Direttore/Membro del Consiglio | 01/11/2020 |
ReOx Ltd.
 ReOx Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs | Fondatore | 01/06/2003 |
The Francis Crick Institute Ltd.
 The Francis Crick Institute Ltd. Investment Trusts/Mutual FundsMiscellaneous Operates as an independent charity that engages in biomedicine research | Corporate Officer/Principal | - |
European Molecular Biology Organization | Corporate Officer/Principal | - |
University of Oxford
 University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
American Academy of Arts & Sciences
 American Academy of Arts & Sciences Miscellaneous Commercial ServicesCommercial Services Operates as organization which honours excellence and convenes leaders | Corporate Officer/Principal | - |
Immunocore Ltd.
 Immunocore Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes transformative medicines for cancer, infection and autoimmune disease | Direttore/Membro del Consiglio | - |
Target Discovery Institute | Direttore/Membro del Consiglio | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 8 |
|---|---|
University of Oxford
University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ReOx Ltd.
ReOx Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs | Health Technology |
American Academy of Arts & Sciences
American Academy of Arts & Sciences Miscellaneous Commercial ServicesCommercial Services Operates as organization which honours excellence and convenes leaders | Commercial Services |
European Molecular Biology Organization | |
The Francis Crick Institute Ltd.
The Francis Crick Institute Ltd. Investment Trusts/Mutual FundsMiscellaneous Operates as an independent charity that engages in biomedicine research | Miscellaneous |
Immunocore Holdings Plc
 Immunocore Holdings Plc BiotechnologyHealth Technology Operates as a biotechnology company which develops immunotherapies | Health Technology |
Target Discovery Institute | |
Immunocore Ltd.
Immunocore Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes transformative medicines for cancer, infection and autoimmune disease | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
